scholarly journals Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population

Thorax ◽  
2001 ◽  
Vol 56 (8) ◽  
pp. 613-616
Author(s):  
P Lange ◽  
J Parner ◽  
E Prescott ◽  
C Suppli Ulrik ◽  
J Vestbo
Keyword(s):  
General Population ◽  
Postmenopausal Women ◽  
Hormone Replacement ◽  
Premenopausal Women ◽  
Cross Sectional Study ◽  
Asthma Medication ◽  
Hormonal Contraceptives ◽  
Cross Sectional ◽  
Heart Study ◽  
Prescription Practice

BACKGROUNDRecent evidence suggests a role for hormonal factors in the aetiology of asthma.METHODSData from a large study of women selected from the general population were used to relate treatment with oral hormonal contraceptives (OCP) and postmenopausal hormone replacement therapy (HRT) to the following asthma indicators: self-reported asthma, wheezing, cough at exertion, and use of medication for asthma. The study sample comprised 1536 premenopausal and 3016 postmenopausal women who participated in the third round of the Copenhagen City Heart Study in 1991–4. A total of 377 women were taking OCP (24.5% of premenopausal women) and 458 were on HRT (15.2% of postmenopausal women).RESULTSIn premenopausal women 4.8% reported having asthma. The prevalence of self-reported asthma, wheeze, use of asthma medication, and cough at exertion was not significantly related to use of OCP. In postmenopausal women the prevalence of self-reported asthma was 6.2%. A weak but consistent association was observed between HRT and self-reported asthma (OR 1.42 (95% CI 0.95 to 2.12)), wheeze (OR 1.29 (95% CI 1.02 to 1.64)), cough at exertion (OR 1.34 (95% CI 1.01 to 1.77)), and use of asthma medication (OR 1.45 (95% CI 0.97 to 2.18)).CONCLUSIONSIn this study of the general population no relationship was found between the use of OCP and asthma. Although an association was observed between HRT and asthma and asthma-like symptoms, this was relatively weak and it is concluded that there is no necessity to change present prescription practice.

scholarly journals Association among age, gender, menopausal status and small dense low-density lipoprotein cholesterol: a cross-sectional study

BMJ Open ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. e041613
Author(s):  
Toshihide Izumida ◽  
Yosikazu Nakamura ◽  
Yukihiro Sato ◽  
Shizukiyo Ishikawa
Keyword(s):  
Postmenopausal Women ◽  
Low Density Lipoprotein ◽  
Menopausal Status ◽  
Density Lipoprotein ◽  
Premenopausal Women ◽  
Cross Sectional Study ◽  
Lipoprotein Cholesterol ◽  
Low Density ◽  
Low Density Lipoprotein Cholesterol ◽  
Cross Sectional

ObjectivesSmall dense low-density lipoprotein cholesterol (sdLDL-C) might be a better cardiovascular disease (CVD) indicator than low-density lipoprotein cholesterol (LDL-C); however, details regarding its epidemiology remain elusive. The present study aimed at evaluating the association between the demographic factors, such as age, gender and menopausal status, and sdLDL-C levels and sdLDL-C/LDL-C ratio in the Japanese population.DesignThis was a cross-sectional study.Setting13 rural districts in Japan, 2010–2017.ParticipantsThis study included 5208 participants (2397 men and 2811 women), who underwent the health mass screening that was conducted in accordance with the medical care system for the elderly and obtained informed consent for this study.ResultsIn total, 517 premenopausal women (mean age ±SD, 45.1±4.2 years), 2294 postmenopausal women (66.5±8.8 years) and 2397 men (64.1±11.2 years) were analysed. In men, the sdLDL-C levels and sdLDL-C/LDL-C ratio increased during younger adulthood, peaked (36.4 mg/dL, 0.35) at 50–54 years, and then decreased. In women, relatively regular increasing trends of sdLDL-C level and sdLDL-C/LDL-C ratio until approximately 65 years (32.7 mg/dL, 0.28), followed by a downward or pleated trend. Given the beta value of age, body mass index, fasting glucose and smoking and drinking status by multiple linear regression analysis, standardised sdLDL-C levels and sdLDL-C/LDL-C ratio in 50-year-old men, premenopausal women and postmenopausal women were 26.6, 22.7 and 27.4 mg/dL and 0.24, 0.15 and 0.23, respectively. The differences between premenopausal and postmenopausal women were significant (p<0.001).ConclusionsSdLDL-C and sdLDL-C/LDL-C ratios showed different distributions by age, gender and menopausal status. A subgroup-specific approach would be necessary to implement sdLDL-C for CVD prevention strategies, fully considering age-related trends, gender differences and menopausal status.

scholarly journals Elevated Cardiovascular Risks among Postmenopausal Women: A Community Based Case Control Study from Nepal

2017 ◽  
Vol 2017 ◽  
pp. 1-5 ◽  
Author(s):  
Bashu Dev Pardhe ◽  
Sumitra Ghimire ◽  
Jyotsna Shakya ◽  
Sabala Pathak ◽  
Shreena Shakya ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Premenopausal Women ◽  
Cross Sectional Study ◽  
Lipoprotein Cholesterol ◽  
Hormonal Changes ◽  
Cardiovascular Risks ◽  
Cross Sectional ◽  
Near Future

Cardiovascular disease (CVD) is one of the leading causes of death worldwide which is more prevalent in women after menopause. Hormonal changes associated with menopause are accountable for dyslipidemic pattern that causes CVD and associated complications. Therefore, the present study was commenced to compare the lipid profile in pre- and postmenopausal women. A descriptive cross-sectional study was conducted at Manmohan Memorial Institute of Health Sciences (MMIHS) from February 2016 to July 2016. A total of 260 fasting samples were collected from healthy women, 130 from premenopausal and 130 from postmenopausal women, and analyzed for Total Cholesterol (TC), Triacylglycerol (TAG), High Density Lipoprotein Cholesterol (HDL-C), and Low Density Lipoprotein Cholesterol (LDL-C) as per the guideline provided by the reagent manufacturer (Human, Germany). All the parameters were analyzed by Stat Fax 3300 semi auto analyzer. TC, TAG, HDL-C, and LDL-C were highly significantly increased in postmenopausal women when compared to premenopausal women. LDL/HDL ratio was significantly elevated in postmenopausal women than in premenopausal women. BMI was significantly positively correlated with TC and TAG in both pre- and postmenopausal population and it was positively correlated with HDL-C in premenopausal population while negatively correlated in postmenopausal population. Since more of the atherogenic lipid parameters are increased in postmenopausal women, they appear to be more prone to have CVD and associated complications in near future. Hence, it is mandatory to monitor and manage dyslipidemic pattern in every woman experiencing menopause.

scholarly journals Understanding the Impact of Periodontal Status in Pre & Post-Menopausal Women with Generalized Chronic Periodontitis and Osteoporosis: A Cross Sectional Study

2017 ◽  
Vol 9 (3) ◽  
pp. 204
Author(s):  
Sameena Sultana
Keyword(s):  
Postmenopausal Women ◽  
Chronic Periodontitis ◽  
Premenopausal Women ◽  
Cross Sectional Study ◽  
Monthly Basis ◽  
Cross Sectional ◽  
Periodontal Status ◽  
Menopausal Women ◽  
Post Menopausal ◽  
The Impact

Chronic periodontitis and osteoporosis are two interconnected medical issues, which usually develops complications in the general public. However, public is mostly unaware of their periodontal status. The research study has aimed to understand the impact of periodontal status among pre and post-menopausal women, suffering from periodontitis and osteoporosis. A cross-section approach has been selected for data collection. 70 patients were selected from the outpatient department of SRM dental college in Chennai. SPSS version 20 has been used for statistical analysis. Postmenopausal women have shown statistically significant poor periodontal status as compared to premenopausal women. Similarly, it has also been evaluated that osteoporosis played a progressive role among postmenopausal women for developing periodontitis. The study leads to the conclusion that pre and post-menopausal women must undergo a periodontal assessment on a monthly basis for developing outcomes related to the risk of fractures. Parameters are closely connected with the levels of calcium according to the tests and assessments.

scholarly journals Assessment of FMO3 SNPs in Relation to TMAO in Generally Healthy United States Adults

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 940-940
Author(s):  
Kristen James ◽  
Erik Gertz ◽  
Catherine Kirschke ◽  
Liping Huang ◽  
Charles Stephensen ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Cystatin C ◽  
A Priori ◽  
Menopausal Status ◽  
Premenopausal Women ◽  
Cross Sectional Study ◽  
Full Cohort ◽  
Cross Sectional ◽  
Relationship Of ◽  
The Relationship

Abstract Objectives The hepatic enzyme flavin monooxygenase 3 (FMO3) oxidizes many metabolites including trimethylamine to the atherogenic molecule trimethylamine n-oxide (TMAO). Variants in the open reading frame of the FMO3 gene alter the enzyme's activity; therefore, we genotyped two a priori missense FMO3 SNPs in a cohort of unmedicated healthy adults. We hypothesized that the SNPs might affect the activity of the encoded enzyme leading to reductions in circulating TMAO. FMO3 expression is upregulated by estrogen, thus we also assessed the relationship of the SNPs and TMAO in pre- and postmenopausal women. Methods DNA was extracted from whole blood from 349 subjects (182 women) who were enrolled in a cross-sectional study at the USDA/ARS WHNRC. SNPs rs2266782 (G &gt; A, p.Glu158Lys) and rs2266780 (A &gt; G, p.Glu308Gly) were genotyped using TaqMan SNP genotyping kits and PCR. TMAO was purified from fasted plasma and quantified using high resolution LC-MS. Regression models were built to assess the relationship of the SNPs to TMAO in the full cohort and by self-reported menopausal status in women. Models assessing the full cohort were adjusted for plasma cystatin C and a sex*age interaction, whereas the menopausal analysis was adjusted for cystatin C. Results The cohort's minor allele frequencies were 36.5% and 17.5% for SNPs rs2266782 and rs2266780, respectively, which were consistent with the genome aggregation exome reports. For both SNPs, median TMAO concentrations increased in individuals carrying the risk alleles, however the differences by genotypes were not significant. In women, the AA genotype at rs2266780 was associated with reduced TMAO levels in pre-, but not postmenopausal women (P = 0.01). This effect was not identified in females with AG or GG genotypes, regardless of their menopausal state. Conclusions Effects of the evaluated FMO3 SNPs on TMAO levels were not identified in the full cohort. However, the SNP rs2266780 was associated with reduced TMAO in premenopausal women with the AA genotype but not women with the AG or GG genotypes, nor those who were postmenopausal. This finding reinforces previous observations that risks for cardiovascular diseases increase after menopause in women. Funding Sources The Beef Checkoff, R01HL128572; USDA-ARS 2032–53,000–001–00-D, 2032–51,530–022–00-D, and 2032–51,000-004–00D; NCATS NIH UL1 TR001860.

scholarly journals Association between hot flashes severity and oxidative stress among Mexican postmenopausal women: a cross-sectional study

2019 ◽  
Author(s):  
Martha A. Sánchez-Rodríguez ◽  
Mariano Zacarías-Flores ◽  
Alicia Arronte-Rosales ◽  
Víctor Manuel Mendoza-Núñez
Keyword(s):  
Oxidative Stress ◽  
Postmenopausal Women ◽  
Hot Flashes ◽  
Premenopausal Women ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Self Rating ◽  
Stress Score ◽  
And Oxidative Stress

AbstractObjectiveTo assess the association between hot flashes (HFs) severity and oxidative stress (OS) in Mexican postmenopausal women.MethodsA cross-sectional study was carried out with perimenopausal women aged 40-59 years community-dwelling from Mexico City, Mexico. They participated in Menopause and Oxidative Stress Project. The baseline sample consisted of 476 women recruited to participate; 161 women were excluded due to different reasons. Hence, 315 women were selected to establish two groups, a) 145 premenopausal women (yet with menstrual bleeding), and b) 170 postmenopausal women (without menses). All women were free of cardiovascular, kidney, hepatic or cancer disease, and without antioxidant supplement intake for at least six months prior to the beginning of the study; none had previously received hormone therapy. As OS markers, we measured plasma malondialdehyde using the TBARS assay, erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx), uric acid, and total antioxidant status; also, we calculated SOD/GPx ratio, antioxidant gap and an oxidative stress score ranging from 0 to 7. The HFs were evaluated using the Menopause Rating Scale. The women completed Spanish version of the Athens Insomnia Scale, Zung Self-Rating Anxiety Scale and Zung Self-Rating Depression Scale and a questionnaire of pro-oxidant factors.ResultsStress score increased with HFs severity (mild 2.9±0.23, moderate 3.1±0.21 and severe 3.8±0.18, p<0.01) in postmenopausal women. We observed a positive correlation between HFs severity and stress score, r=0.247 (p=0.001) in postmenopausal women; other test scores were not correlated. Severe HFs were a risk factor for OS (OR=3.37, 95%CI: 1.20-9.51, p<0.05) in an adjusted multivariate analysis by different postmenopausal symptoms and pro-oxidant factors; we did not see any association in premenopausal women.ConclusionOur findings suggest an association between HFs severity and OS in Mexican postmenopausal women.

scholarly journals Longitudinal associations between sex hormone-binding globulin and insulin resistance

2020 ◽  
Vol 9 (5) ◽  
pp. 418-425
Author(s):  
Kristin Ottarsdottir ◽  
Margareta Hellgren ◽  
David Bock ◽  
Anna G Nilsson ◽  
Bledar Daka
Keyword(s):  
Insulin Resistance ◽  
Postmenopausal Women ◽  
Hormone Replacement ◽  
Premenopausal Women ◽  
Sex Hormone Binding Globulin ◽  
Model Assessment ◽  
Cross Sectional ◽  
Men And Women ◽  
Significant Difference ◽  
Homeostatic Model Assessment

Purpose We aimed to investigate the association between SHBG and the homeostatic model assessment of insulin resistance (HOMA-Ir) in men and women in a prospective observational study. Methods The Vara-Skövde cohort is a random population of 2816 participants living in southwestern Sweden, aged 30–74. It was recruited between 2002 and 2005, and followed up in 2012–2014. After excluding participants on insulin therapy or hormone replacement therapy, 1193 individuals (649 men, 544 women) were included in the present study. Fasting blood samples were collected at both visits and stored in biobank. All participants were physically examined by a trained nurse. SHBG was measured with immunoassay technique. Linear regressions were computed to investigate the association between SHBG and HOMA-Ir both in cross-sectional and longitudinal analyses, adjusting for confounding factors. Results The mean follow-up time was 9.7 ± 1.4 years. Concentrations of SHBG were significantly inversely associated with log transformed HOMA-Ir in all groups with estimated standardized slopes (95% CI): men: −0.20 (−0.3;−0.1), premenopausal women: −0.26 (−0.4;−0.2), postmenopausal women: −0.13 (−0.3;−0.0) at visit 1. At visit 2 the results were similar. When comparing the groups, a statistically significant difference was found between men and post-menopausal women (0.12 (0.0;0.2) P value = 0.04). In the fully adjusted model, SHBG at visit 1 was also associated with HOMA-Ir at visit 2, and the estimated slopes were −0.16 (−0.2;−0.1), −0.16 (−0.3;−0.1) and −0.07 (−0.2;0.0) for men, premenopausal and postmenopausal women, respectively. Main conclusion Levels of SHBG predicted the development of insulin resistance in both men and women, regardless of menopausal state.

scholarly journals Study of metabolic syndrome in postmenopausal women

2015 ◽  
Vol 1 (1) ◽  
pp. 6-11 ◽  
Author(s):  
Alina Shri Sapkota ◽  
Alisha Sapkota ◽  
Kamananda Acharya ◽  
Mithileshwer Raut ◽  
Bharat Jha
Keyword(s):  
Metabolic Syndrome ◽  
Postmenopausal Women ◽  
Abdominal Obesity ◽  
Biochemical Markers ◽  
Premenopausal Women ◽  
Cross Sectional Study ◽  
Asian Women ◽  
Health Checkup ◽  
Cross Sectional ◽  
Serum Biochemical

BACKGROUND: Various studies throughout the world have documented higher prevalence of Metabolic Syndrome (MS) and CV risk factors in postmenopausal women. Abdominal obesity, a key component of metabolic syndrome is quite prevalent in South Asian women. However, studies that have investigated the effect of menopause on the health status of Nepalese women is lacking. METHODS: This cross-sectional study was conducted in TUTH, Kathmandu Nepal. Forty five each premenopausal and postmenopausal (defined by cessation of menstruation for ≥12 months) women visiting the General Health Checkup Unit were enrolled as participants. Metabolic syndrome was defined by IDF criteria. BP, height, weight and WC were measured and BMI was calculated while fasting blood samples were analyzed for serum biochemical markers: FBG, lipid profile. RESULTS: This study found higher prevalence of MS in postmenopausal women (57.8%) in comparison to premenopausal women (20%). 13.3% were diabetic, 23.3% were hypertensive, 82.2% had abdominal obesity (WC>80 cm), 43.3% were overweight (BMI 25-29.99 Kg/m2) and 13.3 % were obese (BMI≥30 Kg/m2). WC, BMI and SBP were significantly higher in postmenopausal group. Among the biochemical markers, FBG, TC, LDL-C, TG were significantly higher whereas HDL-C was significantly lower in postmenopausal women than in premenopausal women. CONCLUSION: MS was highly prevalent in postmenopausal women. This is an indication of taking necessary preventive measures so that the risk of developing diabetes and cardiovascular disease can be minimized in the postmenopausal group. DOI: http://dx.doi.org/10.3126/acclm.v1i1.12307 Ann. Clin. Chem. & Lab. Med. 1(1) 2015: 6-11

Sign in / Sign up

Export Citation Format

Share Document